Showing results (61-70 of 435) with videos related to
Sort By:
Pageof 44
Seminars in Oncology|October 19, 2013
The future of drug development and therapy in myelomaSagar Lonial, Lawrence H BoiseOncology (Williston Park, N.Y.)|September 5, 2014
Current advances in novel proteasome inhibitor-based approaches to the treatment of relapsed/refractory multiple myelomaSagar Lonial, Lawrence H BoisePharmacotherapy|February 5, 2022
Impact of concurrent gabapentin or pregabalin with high-dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantAkhilesh Sivakumar, Evan B Bryson, Kevin H Hall, et al.CA: a Cancer Journal for Clinicians|January 10, 2023
Chimeric antigen receptor T-cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practiceRujul H Parikh, Sagar LonialBiologics : Targets & Therapy|February 13, 2016
Emerging treatments in Castleman disease - a critical appraisal of siltuximabJean L Koff, Sagar LonialClinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Novel drug combinations for the management of relapsed/refractory multiple myelomaSaad Z Usmani, Sagar LonialCurrent Opinion in Oncology|September 5, 2020
Practical approach to the management of smoldering myelomaNisha S Joseph, Sagar LonialCancer|October 18, 2018
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agentsRoberto Mina, Nisha S Joseph, Jonathan L Kaufman, et al.JCO Oncology Practice|July 7, 2023
Impact of Black Race on Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma Receiving Bortezomib InductionLaura F Sun, Kathryn T Maples, Kevin H Hall, et al.Current Hematologic Malignancy Reports|April 29, 2010
Treatment of relapsed and refractory myelomaJonathan Kaufman, Charise Gleason, Sagar LonialPageof 44